Topical vitamin D3 analogues: unapproved uses, dosages, or indications.
Parish
Jennifer L
JL
Department of Dermatology and Cutaneous Biology, Jefferson Medical College of Thomas Jefferson University, Philiadelphia, Pennsylvania, USA. jenderm@yahoo.com
D000287:Administration, Topical; D002762:Cholecalciferol / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D018849:Controlled Clinical Trials as Topic; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D004363:Drug Utilization; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D018570:Risk Assessment; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D014481:United States
D003879:Dermatologic Agents; D002762:Cholecalciferol